HOME >> BIOLOGY >> NEWS
M. D. Anderson team identifies new oncogene for brain cancer

HOUSTON -- An overexpressed gene found at the scene of a variety of tumors is implicated in the development of two types of malignant brain cancer in a paper by researchers at The University of Texas M. D. Anderson Cancer Center to be published in the Proceedings of the National Academy of Sciences. The paper will be posted online at the PNAS web site the week of July 2.

Just because a gene is associated with cancer doesnt mean that its actually causing cancer. In this paper we show for the first time that insulin-like growth factor binding protein 2 (IGFBP2) connects with two other proteins to fuel development and progression of brain tumors, says senior author Wei Zhang, Ph.D., professor in M. D. Andersons Department of Pathology.

Using a gene transfer delivery system in a mouse model, a team led by Zhang and Professor of Pathology Gregory Fuller, M.D., Ph.D., shows that IGFBP2 plays an active role in the tumorigenesis of astrocytoma and oligodendroglioma. Both cancers are forms of glioma, cancers that develop in the glial cells which normally support and nourish neurons -- that are highly resistant to treatment.

This makes IGFBP2 an important candidate for development of targeted therapy to treat gliomas, Zhang says. Gliomas kill about 13,000 people in the United States annually.

The possibilities are not limited to brain cancer, Fuller notes, because of the pervasive overexpression of IGFBP2 documented in other cancer types. The gene is expressed only at low levels in normal cells, which would potentially reduce side effects caused by a treatment that targeted the gene or its protein product.

Fuller and Zhang first associated overexpression of the gene with brain cancer in 1999. Other researchers have since found it to be overexpressed in prostate, ovarian, breast and colorectal cancers, some leukemias, and also in drug-resistant tumors.

Overabundance of IGFBP2 has since been shown to be a
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
2-Jul-2007


Page: 1 2 3

Related biology news :

1. New research identifies anti-viral protein that may predict who might be at risk to develop lupus
2. U-M team identifies gene that regulates blood-forming fetal stem cells
3. Study identifies new gene therapy tools for inherited blindness
4. Study identifies energy efficiency as reason for evolution of upright walking
5. Study identifies a common genetic risk factor for colorectal and prostate cancer
6. Weill Cornell team identifies potential new cancer drug target
7. Study identifies 5 genetic themes key to keeping stem cells in a primitive, flexible state
8. 454 sequencing identifies HIV drug resistance at early stage
9. Ultra deep sequencing identifies HIV drug resistance at early stage
10. Research team identifies new Alzheimers gene
11. A researcher identifies the parasites responsible for Chagas and Leishmaniasis epidemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/21/2019)... (PRWEB) , ... December 20, 2019 , ... The City ... Convention and SAGICO was on hand to honor these heroes. Tampa welcomed these most-highly ... leaders, veteran organizations and community leaders honored these distinguished service members. , The Medal ...
(Date:12/18/2019)... , ... December 17, 2019 , ... ... pharmaceutical, biotech, medical device, and diagnostics industries, has named Pharmafusion LLC as one ... impressive year for the company and its founder/CEO Jonathan Retano. Earlier in the ...
(Date:12/14/2019)... ... December 11, 2019 , ... ... the food and beverage industry won the 2019 Food Ingredient Europe’s plant-based innovation ... the rapidly growing plant-based foods category. Fiberstar who was one of three finalists ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... ALPHARETTA, Ga. (PRWEB) , ... December 03, 2019 , ... ... representatives, revealed Syneos Health, Teleflex, and CONMED as the overall best medical sales companies ... Work in Medical Sales survey polled over 1,200 professionals from the MedReps community ...
(Date:12/4/2019)... ... December 04, 2019 , ... Improved Pharma’s analytical ... amorphous materials. Additionally, their PDF Synchrotron methods provide a way to determine the ... both in regulatory and patent applications.  , The latest developments were recently shared ...
(Date:11/22/2019)... ... November 22, 2019 , ... ... live webinar covering a step-by-step cold chain validation guide to meet and ... therapies. Targeting complex cold chain biopharmaceutical industry leaders, the September 19, 2019 ...
(Date:11/12/2019)... ... 2019 , ... REPROCELL Inc. a stem cell and drug ... to provided preclinical screening and drug sensitivity for its portfolio of oncology drugs. ... unique and genetically edited cell lines from various tumors. The data generated from ...
Breaking Biology Technology:
Cached News: